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Bromodomain functions as the acetyl-lysine bind-
ing domains to regulate gene transcription in chro-
matin. Bromodomains are rapidly emerging as new
epigenetic drug targets for human diseases. How-
ever, owing to their transient nature and modest
affinity, histone-binding selectivity of bromodomains
has remained mostly elusive. Here, we report high-
resolution crystal structures of the bromodomain-
PHD tandem module of human transcriptional
coactivator CBP bound to lysine-acetylated histone
H4 peptides. The structures reveal that the PHD
finger serves a structural role in the tandem module
and that the bromodomain prefers lysine-acetylated
motifs comprising a hydrophobic or aromatic residue
at 2 and a lysine or arginine at 3 or 4 position
from the acetylated lysine. Our study further provides
structural insights into distinct modes of singly and
diacetylated histone H4 recognition by the bromodo-
mains of CBP and BRD4 that function differently as a
transcriptional coactivator and chromatin organizer,
respectively, explaining their distinct roles in control
of gene expression in chromatin.
INTRODUCTION
The bromodomain (BrD) recognition of acetylated lysine resi-
dues in histones is a fundamental molecular mechanism in
control of gene transcription in chromatin (Dhalluin et al., 1999;
Sanchez and Zhou, 2009). BrD and acetyl-lysine binding serves
to modulate chromatin structure opening, facilitate the recruit-
ment of transcription factors to target gene promoter and
enhancer sites, and promote the assembly and activation of
the paused RNA polymerase II machinery complex for
productive gene transcription (Chiang, 2009). Owing to their
key functions in gene activation, the BrDs of transcription-asso-
ciated proteins such as BET (bromodomain and extra-terminal
domain) proteins (Dawson et al., 2011; Delmore et al., 2011; Fil-
ippakopoulos et al., 2010; Nicodeme et al., 2010; Zhang et al.,
2012; Zuber et al., 2011) and transcription coactivators CBP
(Borah et al., 2011) and PCAF (Zeng et al., 2005) have been re-
ported as new epigenetic drug targets for a wide array of human
diseases, including cancer and inflammation.Structure 22, 35Acetylation at site-specific lysine residues in nucleosomal his-
tones represents distinct biological functions to direct ordered
gene transcription. For instance, single acetylation of histone
H3 at Lys14 (H3K14ac) or Lys18 (H3K18ac) marks for chromatin
remodeling,whereasdiacetylationof histoneH4at Lys5andLys8
(H4K5ac/K8ac) or Lys12 and Lys16 (H4K12/K16ac) signals an
active state of gene transcription. In contrast to histone methyl-
lysine binding protein modules such as chromodomains and
PHD fingers (Patel and Wang, 2013; Yap and Zhou, 2010), BrD/
acetyl-lysine interactions are typically transient and of modest
tens-to-hundreds micromolar affinity (Filippakopoulos et al.,
2012). As such, histone binding selectivity of human BrDs has
remained mostly elusive. The human BrD family consists of 61
members residing in 46 proteins of different chromatin- and
transcription-associated functions (Figure 1A). Of these are two
distinct subgroups representing the histone acetyltransferase
transcriptional coactivators, including CBP/p300 and PCAF,
and the BET family proteins that are characteristic of two tandem
BrDs such as BRD4. The latter have been extensively character-
ized recently (Filippakopoulos et al., 2012; Morinie`re et al., 2009).
However, despite their equally important functions for lysine
acetylation in gene activation, the histone binding selectivity of
the former subgroup of BrDs is not well understood.
Notably, it has been previously reported by Ragvin and
coworkers that theBrD-PHD finger tandemmodule of human co-
activator p300 binds to nucleosomes with a high degree of lysine
acetylation and that this binding requires thepresence of both the
bromodomain and the PHD finger (Ragvin et al., 2004). Further-
more, our recent nuclear magnetic resonance (NMR) binding
analysis revealed that the BrD of CBP, which shares 98%
sequence identity to that of p300, exhibits a preference for bind-
ing to Lys20-acetylated histoneH4 (H4K20ac;GGARKRHR-Kac-
VLRDNIQ, residues 13–27) over other lysine-acetylated histone
peptides, of which the molecular underpinning is not well under-
stood (Zenget al., 2008b).Determinationof histonebinding spec-
ificity of BrDs would require detailed knowledge of the molecular
basis of BrD recognition of functionally relevant acetylated
histone peptides. In this study, we report two crystal structures
of the BrD-PHD finger tandem module of CBP in complex with
lysine-acetylated histone H4 peptides.
RESULTS AND DISCUSSION
Structures of the CBP BrD-PHD Module/Acetylated H4
Peptide Complexes
To determine histone binding selectivity of the CBPBrD and how
it functions together with the adjacent PHD finger, we solved the3–360, February 4, 2014 ª2014 Elsevier Ltd All rights reserved 353
Figure 1. Crystal Structure of CBP BrD-PHD in Complex with H4K20ac Peptide
(A) Domain organization of CBP and other human BrD proteins (left). Phylogenetic tree of human BrD proteins (right).
(B) Ribbon depiction of 3D structure of the tandem BrD (green) and PHD finger (orange) of CBP bound to a histone H4K20ac peptide (shown in sticks with carbon
atoms in yellow). The linker of the BrD-PHD module is colored in light cyan and regions that lack electron density are indicated by dots. Zinc atoms are shown in
magenta spheres.
(C) Surface-filled representation of the CBP BrD-PHD/H4K20ac complex structure.
(D) Electrostatic surface potential representation of the CBP BrD-PHD/H4K20ac structure.
See also Figure S1.
Structure
Structure and H4 Recognition of CBP BrD-PHD Modulecrystal structures of the BrD-PHD tandemmodule of humanCBP
in complex with a lysine-acetylated histone H4 peptide (residues
5–25) containing either H4K20ac (KGGKG-LGKGGAKRHR-Kac-
VLRDN where Kac is acetylated lysine; Figures 1B–1D; Figures354 Structure 22, 353–360, February 4, 2014 ª2014 Elsevier Ltd All rS1A and S1B available online) or H4K12ac/K16ac (KGGKGLG-
Kac-GGA-Kac-RHRKVLRDN) at 1.9 A˚ and 1.83 A˚ resolution,
respectively (Table 1). The new structures revealed that the
BrD and the PHD finger in the tandem domain establish directights reserved
Table 1. Crystallography Data and Refinement Statistics
CBP-BP/H4K20ac CBP-BP/H4K12ac/K16ac
PDB code 4N3W 4N4F
Data collection
Space group C121 C121
Cell dimensions
a, b, c (A˚) 92.46, 59.31,
53.44
92.01, 59.46, 53.88






Rmerge (%) 5.1 (32.2) 4.9 (48.9)
I/sI 35.9 (5.6) 26.7 (2.7)
Completeness (%) 98.7 (93.8) 98.4 (96.9)
Redundancy 7.4 (7.1) 4.9 (4.4)
Refinement
Resolution (A˚) 19.6–1.9 19.69–1.83
No. of reflections 20,884 23,279
Rwork/Rfree (%) 23.2/28.3 20.9/24.2
No. of atoms 1,709 1,785
Rmsd
Bond length (A˚) 0.016 0.02
Bond angle () 1.8 1.7
Structure
Structure and H4 Recognition of CBP BrD-PHD Moduleinteractions forming a single structural unit. Specifically, the CBP
BrD adopts the classical left-handed four-helix bundle structure
in complex with the acetylated H4 peptide. Either H4-peptide-
bound structure of the BrD is nearly identical to that of the protein
in the free state with root-mean-square deviations (rmsd) of
0.46 A˚ and 0.47 A˚ for all Ca atoms, respectively. The PHD finger
is packaged against the BrD between helix B and helix C at one
end of the helical bundle opposite from the acetyl-lysine binding
pocket. A significant portion of the long linker connecting the two
modular domains including residues 1212–1251 and 1262–1270
were missing in the electron density in the X-ray crystallography
data, suggesting a high degree of structural mobility in solution.
Notably, this structural observation of the CBPBrD-PHDmod-
ule was confirmed by a newly reported crystal structure of the
p300 catalytic core by Delvecchio et al. (2013), which consists
of the BrD-PHD finger-histone-acetyltransferase (HAT) tandem
module, solved in the absence of an acetylated histone peptide.
This latter structure reveals that the region of residues 1168–
1242 in p300 comprises a CH2-containing RING domain, which
interacts with the HAT catalytic domain and was speculated to
play a role in control of the HAT activity toward a biological
ligand. In our construct of the tandem BrD-PHD finger of CBP,
we observed only partial electron density of the RING domain.
The region in which we could trace electron density to the back-
bone atoms of several amino acid residues with confidence
adapts a different conformation as compared to that in the
p300 catalytic core structure, suggesting that this RING domain
is very flexible. Nevertheless, it is worth noting that these repre-
sent high-resolution crystal structures of the BrD-PHD finger
tandem module of CBP, as well as of the CBP BrD bound to
lysine-acetylated histone peptides. Therefore, our structural
feature analysis as described in detail below provides previouslyStructure 22, 35unreported insights into the molecular functions of CBP in con-
trol of gene transcription in chromatin.
BrD-PHD Finger Interactions
The PHD finger of CBP has the canonical PHD finger fold that is
composed of a small two-stranded b sheet packaged on one
side by a short a helix that is stabilized by two zinc atoms
coordinated by Cys1199, Cys1200, His1291, and Cys1294 and
Cys1283, Cys1286, Cys1308, and Cys1311, respectively (Fig-
ure 2A). The two zinc coordination centers also serve as a stable
base for an extended interface established between the PHD
finger and the BrD. This interdomain interface comprises
a network of hydrophobic/aromatic and electrostatic interac-
tions involving Asp1149 with Lys1289, Trp1151 with Phe1280,
Asp1155 with Lys1203, Trp1158 with Tyr1204, and Tyr1198 with
Arg1288 of the BrD and the PHD finger, respectively (Figure 2B).
Notably, while many of these residues involved in interdomain
interactions are conserved in CBP or p300 from different species
from human to mouse, they are not all present in the BrDs from
many different types of transcription-associated proteins, partic-
ularly BET proteins and those that do not contain BrD and PHD
finger tandem modules (Figure S2). Domain-domain interactions
or orientation even in the BrD-PHD finger or PHD finger-BrD
tandem modules varies widely, as shown in comparison of such
tandem module structures from BPTF (Li et al., 2006), TRIM24
(Tsai et al., 2010), TRIM28 (Zeng et al., 2008a), and TRIM33 (Xi
et al., 2011) (Figure 2C). This suggests that domain-domain orien-
tation in the tandemmodules is likely related to specific functions
of the individual domains or of the overall tandemmodules, which
have diverse functionality in molecular interactions with histones
in control of gene transcription. Indeed, unlike the other tandem
modules that interact with histones, the tandem PHD finger-BrD
of human corepressor TRIM28 (also known as KRAB-associated
protein or KAP1) functions as a unique small ubiquitin-like modi-
fier E3 ligase for gene transcription silencing (Zeng et al., 2008a).
The Structural Role of the PHD Finger in the Tandem
Module
We performed extensive NMR 15N-heteronuclear single quan-
tum correlation (HSQC) titration of the 15N-labeled tandem
BrD-PHD finger of CBP as well as the individual PHD finger
with a set of histone H3 and H4 peptides in the free form or
with site-specific lysine methylation such as H3K4me3,
H3K9me3, H3K27me3, and H4K20me3. We did not observe
any specific histone peptide binding by the PHD finger, either
in the tandem module or in its individual construct (Figure S3).
Our results are consistent with a recent study of the CBP PHD
finger that does not interact with histones (Park et al., 2013).
To investigate the structure-function relationship of the CBP
PHD finger, we compared its structural features to those of the
BPTF PHD finger that is known to bind to H3K4me3 (Li et al.,
2006). Notably, although the overall structures of the two PHD
fingers are very similar with rmsd of 2.8 A˚ for all Ca atoms (Fig-
ure 2D) and a possible H3 peptide binding site in the CBP BrD-
PHD finger tandem module that would also be accessible, the
key aromatic cage residues such as Tyr10, Tyr17, and Trp32 in
the BPTF for the H3K4me3 recognition are absent in the CBP
PHD finger (Figure 2E). This explains its lack of interactions
with the histone peptides. Moreover, the overall structure of3–360, February 4, 2014 ª2014 Elsevier Ltd All rights reserved 355
Figure 2. Molecular Basis of Histone Recognition of the BrD-PHD Module of CBP
(A) A close-up view of the PHD finger of CBP. The residues coordinating the zinc atoms (in magenta spheres) are in sticks and labeled.
(B) Interdomain interactions of the Brd and the PHD finger of CBP.
(C) Structural comparison of the tandemBrD-PHD finger modules of CBP, BPTF, TRIM24, TRIM28, and TRIM33. PHDmodules are colored in orange, BrDs are in
blue, CBP is in green, and linkers between domains are in light cyan. Zinc atoms are shown in magenta spheres.
(D) Superimposition of CBP and BPTF PHDmodules. The domain is represented in cartoons and is colored in orange and salmon for CBP and BPTF, respectively.
Zinc atoms are shown in magenta and salmon spheres for CBP and BPTF, respectively. On the right is a surface representation of BPTF PHD finger bound to
H3K4me2 peptide (shown in sticks with carbon atom labeled in yellow). The residues comprising aromatic cage are shown in sticks.
(E) A surface representation of a model of CBP bound to H3K4me2 peptide. The orientation is as in (A).
(F) Close-up view of a model of the CBP PHD finger bound to H3K4me2 peptide. The residues close to the methylated lysine and line up the groove of the domain
are shown in sticks and labeled.
See also Figures S2 and S3.
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Structure and H4 Recognition of CBP BrD-PHD Modulethe CBP BrD-PHD module bound to the acetylated H4K20ac
peptide is very similar to that in the free-form structure of the
p300 BrD-PHD finger-HAT module (Delvecchio et al., 2013).
Taken together, these results support our notion that this PHD
finger plays a structural role in the BrD-PHD finger tandemmod-
ule, which serves as one functional unit in assisting substrate
recognition for the histone acetyltransferase activity of CBP.356 Structure 22, 353–360, February 4, 2014 ª2014 Elsevier Ltd All rSite-Specific Acetylated H4 Recognition by the BRD
Bromodomain
The crystal structures of the BrD-PHD module bound to the
two acetylated-H4 peptides reveal the atomic-level details of
the molecular basis of histone binding selectivity by the CBP
BrD. Both H4 peptides contain the same H4 residues 5–25
but carry different lysine acetylation sites, i.e., H4K20ac ofights reserved
Structure
Structure and H4 Recognition of CBP BrD-PHD ModuleKGGKGLGKGGA-KRHR-Kac-VLRDN and H4K12ac/K16ac
of KGGKGLG-Kac-GGA-Kac-RHRKV-LRDN. Notably, only a
small portion of each H4 peptide (underlined in the H4 peptides)
was observed in the electron density, which is centered on one
acetylated lysine bound to the CBP BrD (Figure 3A). Despite the
different amino acid residues in their sequence, the two H4 pep-
tides bound to the BrD adopt an almost identical conformation
across the surface-exposed ligand-binding pocket formed be-
tween the ZA and BC loops. Similarly, little structural deviations
of the BrDs when bound to the two H4 peptides were observed
for backbone or side-chain conformation of several key resi-
dues in the acetyl-lysine binding pocket. Of the most notable
is the conserved Asn1168 that forms an essential hydrogen
bond to the acetyl group of a single bound acetylated lysine,
H4K20ac or H4K12ac. Notably, the side chains of His18 in the
H4K20ac peptide and Leu10 in the H4K12ac/K16ac peptide
are orientated in a nearly identical position and interact with
Pro1123 of the CBP BrD. Additionally, the side-chain amino
group of Lys8 in the H4K12ac/K16ac peptide is engulfed in
electrostatic interactions with a cluster of backbone oxygen
atoms of Trp1165, Leu1166, Tyr1167, and Asn1168 that form
the last C-terminal turn of helix B (Figure 3B). This set of interac-
tions appears partially fulfilled by Arg19 in the H4K20ac peptide
(Figure 3C). Collectively, these structural insights suggest that
the CBP BrD prefers to interact with singly lysine-acetylated
motifs compromising a hydrophobic or aromatic amino acid
at2 and a lysine or arginine at3 or4 position from the acet-
ylated lysine. This consensus recognition sequence agrees with
our previous NMR structural analysis of the CBP BrD recogni-
tion of H4K20ac (Zeng et al., 2008b), as well as activated,
acetylated tumor repressor p53 at K382ac (QSTSRHK-Kac-
LMFKTEG, residues 375–389; Mujtaba et al., 2004). The latter
has been shown to play an important role for p53 recruitment
of the HAT coactivator CBP to its target gene transcription
activation in response to DNA damage repair (Mujtaba et al.,
2004, 2006).
Differences of Histone Binding Specificity by CBP and
BRD4 Bromodomains
We next performed structural comparison of lysine-acetylated
histone H4 recognition by the BrDs of CBP and BRD4 that
have distinct functions in gene transcriptional regulation in chro-
matin. Unlike the CBP BrD (Figures 3D and S4), the two BrDs of
BRD4, as well as other members of the BET protein family, have
been shown to prefer a characteristic diacetylated histone
H4 sequence, particularly H4K5ac/K8ac, of which H4K5ac
serves as the anchoring acetyl-lysine hydrogen bonded to the
conserved Asn140 in BRD4-BrD1 (Filippakopoulos et al.,
2012; Morinie`re et al., 2009). Strikingly, five stably bound water
molecules in the acetyl-lysine binding pocket in the BrDs of CBP
and BRD4-BrD1 are located at almost identical positions (Fig-
ure 3E), of which one water forms two hydrogen bonds, one
to oxygen of the acetyl-lysine and the other to the phenoxy
group of the conserved Tyr1125 in CBP and Tyr97 in BRD4 (Fig-
ure 3F). The second acetylated-lysine H4K8ac in the H4K5ac/
K8ac peptide adds hydrophobic and aromatic interactions
with Trp81, Pro82, Leu92, and Ile146 that form a shallow cavity
located in the ZA channel and the Trp-Pro-Phe shelf (Figure 3G).
Notably, the long side-chain of Arg1173 in the CBP BrD wouldStructure 22, 35block off H4K8ac binding due to a steric collision with the
H4K5acK8ac peptide, thus explaining that the CBP BrD likely
binds only singly acetylated lysine in histones, whereas the
BRD4 BrDs could accommodate interactions with diacetylated
histone H4.
Conclusions
BrD/acetyl-lysine recognition is a fundamental molecular
mechanism that modulates a variety of protein-protein interac-
tions between histones and non-histone proteins required for
controlled gene transcriptional activation in chromatin. Because
of the large size of the human BrD family, it is likely that different
subgroups of BrDs possess different functions in gene tran-
scription. Due to the transient nature and modest affinity of
individual BrD/acetyl-lysine interactions, in vitro biochemical
binding analysis alone is not adequate to determine binding
specificity of BrDs to histones and non-histone transcriptional
proteins. In this study, we present the high-resolution X-ray
crystal structures of the CBP BrD-PHD finger tandem module
in complex with two different acetylated histone H4 peptides,
which contain H4K20ac and H4K12ac/K16ac, respectively.
Our detailed structural analysis reveals that the PHD finger plays
a structural role in the BrD-PHD tandem module and that the
CBP BrD clearly exhibits a preference for a singly acetylated
sequence motif compromising a hydrophobic or aromatic
amino acid at 2 and a lysine or arginine at 3 or 4 position
from the acetylated lysine.
Our study further provides structural insights into distinct
modes of singly and diacetylated histone H4 recognition by
the BrDs of CBP and BRD4 that function differently as a tran-
scriptional coactivator and a chromatin organizer, respectively.
Given that BrDs are rapidly emerging as new epigenetic drug
targets for treatment of a wide array of human diseases and
that the functional differences of CBP as a major transcription
coactivator and BRD4 as a key chromatin organizer, this struc-
tural knowledge is expected to facilitate future mechanistic
investigation of the role of site-specific lysine acetylation in his-
tones and transcription proteins in control of gene transcription
in chromatin.
EXPERIMENTAL PROCEDURES
Preparation of Proteins and Peptides
DNA fragment encoding the BrD-PHD finger module of human CBP (residues
1081–1316) was amplified by PCR and subcloned into the pET28a-LIC vector,
downstreamof the polyhistidine coding region. The CBPBrD-PHDprotein was
overexpressed inE. coliBL21 (DE3) codon plus RIL strain (Stratagene) by addi-
tion of 1mM isopropyl-1-thio-D-galactopyranoside and incubated overnight at
18C. Harvested cells were resuspended in 50 mM sodium phosphate buffer,
pH 7.4, supplemented with 500 mM sodium chloride, 5 mM imidazol, 2 mM
b-mercaptoethanol, and 5% glycerol and lysed using a microfluidizer (Micro-
fluidics) at 20,000 psi. After clarification of the crude extract by high-speed
centrifugation, the lysate was loaded onto a 5 ml HiTrap chelating column
(GE Healthcare) charged with Ni2+. The column was washed, and the protein
was eluted with 20 mM Tris-HCl buffer, pH 8.0, 250 mM sodium chloride,
250 mM imidazole, and 5% glycerol. The protein was next purified on a
Superdex200 column (26 3 60; GE Healthcare) equilibrated with 20 mM
Tris-HCl buffer, pH 8.0, and 150 mM sodium chloride. The protein was treated
with thrombin (Sigma) to cleave off its His-tag, and it was further purified to
homogeneity by ion-exchange chromatography. The BrDs of BRD4 were
purified by affinity chromatography on a nickel- iminodiacetic-acid column
(Invitrogen), followed by the removal of poly-His tag by thrombin cleavage3–360, February 4, 2014 ª2014 Elsevier Ltd All rights reserved 357
Figure 3. Molecular Insights into H4 Recognition by the BrDs of CBP versus BRD4
(A) A close-up view of superimposed crystal structures of CBP BrD-PHD bound to H4K20ac (yellow) and H4K12ac/K16ac (white). The H4 peptides are color
coded by atom type.
(B and C) Close-up views of acetylated H4 binding sites in the individual structure of CBP BrD-PHD bound to H4K20ac (yellow) and H4K12ac/K16ac (white). Key
protein residues interacting with the peptides are shown in sticks.
(D) Binding affinity of lysine-acetylated H4 peptides by the BrDs of CBP and BRD4, determined in a fluorescence anisotropy assay. The H4 peptides H4K5ac/
K8ac, H4K12ac/K16ac, and H4K20ac consist of H4 residues 1–13, 5–25, and 17–23, respectively.
(E) Superimposition of ligand-binding pockets of CBP BrD and BRD4-BrD1. The ligand binding sites are shown in transparent surfaces and colored in gray and
light orange for CBP BrD and BRD4-BrD1, respectively. H4K5ac/K8ac peptide of BRD4-BrD1-H4K5ac/K8ac complex and H4K20ac peptide of CBP-BrD-PHD/
H4K20ac complex are colored in cyan and gray, respectively. Acetyl-lysine residues are shown in sticks. Water molecules tightly bound in the ligand binding sites
are shown in spheres. In the left panel, CBP protein chain is shown in cartoon and colored in green.
(F) The role of water molecules in acetyl-lysine recognition by the BrDs. Schematic diagram of the interaction between water molecules in acetyl-lysine binding
sites of CBP-H4K20ac and BRD4-BrD1-H4K5ac8Kac complexes. Water molecules are shown in spheres, hydrogen bonds are drawn in dashed line, and donor-
acceptor distances are given. The figure was generated by using the program LIGPLOT.
(G) Structural comparison of singly and dually lysine-acetylated H4 peptides byCBP (left) and BRD4BrDs (middle), respectively. CBP andBRD4 are shown in light
gray surfaces, carbon atoms of H4K20Ac and H4K5Ac8Ac peptides are colored in yellow and cyan, respectively, residues interacting with peptides are shown in
(legend continued on next page)
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Structure
Structure and H4 Recognition of CBP BrD-PHD Moduleusing a procedure described previously (Zhang et al., 2012). Isotope-labeled
proteins of the individual BrDs and the PHD and the CBP BrD-PHD finger
were prepared from cells grown on a minimal medium containing 15NH4Cl.
The synthetic histone peptides were synthesized by GenScript and confirmed
by liquid chromatography-mass spectrometry analysis.
NMR Study
The protein (0.2 mM) and histone peptides (1.2 mM) were prepared in a
100 mM sodium phosphate buffer of pH 7.4, containing 5 mM perdeuterated
DTT and 0.5 mM EDTA in H2O/
2H2O (9/1). All two-dimensional
1H-15N HSQC
NMR spectra were collected with a 500 MHz or 600 MHz NMR spectrometer
at 25C.
Fluorescence Anisotropy Binding Assay
Binding affinity of lysine-acetylated histone peptides for the BrDs of CBP and
BRD4 was assessed in a fluorescence anisotropy competition assay using
a fluorescein isothiocyanate-labeled BrD inhibitor as an assay probe as
described previously (Zhang et al., 2012). Competition experiments were
performed with a protein (0.25–1 mM) and the fluorescent probe (80 nM) and
increasing concentrations of unlabeled competing ligand in a PBS buffer
(pH 7.4) in total volume of 80 mL. Measurements were obtained after a 1 hr
incubation of the fluorescent ligand and the protein at 25C with a Safire 2
microplate reader (Tecan). In a competition-binding assay, fluorescent ligand
concentration was% 2 KD, and protein concentration was set at which 50%–
80% of fluorescent ligand is bound. Dissociation constant of a competing
ligand was calculated with the correction to Cheng-Prussoff equation intro-
duced by Nikolovska-Coleska et al. (2004). Assuming one-site competitive
binding model, the equation used to calculate Ki from IC50 values recovered









where [I50] is the concentration of free inhibitor at 50% inhibition, [L50] is the
concentration of free labeled ligand at 50% inhibition, and [P0] is the concen-
tration of free protein at 0% inhibition. Note that KD for each protein-probe pair
is the limit of resolvable Ki in a competition assay.
Crystallization of Human CBP BrD-PHD Protein
Purified CBP BrD-PHD protein (15 mg/mL) was crystallized in complex with
either histone H4K20ac peptide (residues 13–26 of H4) or H4K12ac/K16ac
(residues 5–25 of H4) at 1:10 molar ratio of protein:H4 using the sitting drop
vapor diffusion method at 20C by mixing 1 ml of protein solution with 1 ml of
the reservoir solution. The CBP BrD-PHD/H4K20ac complex was crystallized
in 25% polyethylene glycol (PEG) 3,350, 0.2 Mmagnesium chloride, and 0.1 M
HEPES pH 7.5. The CBP BrD-PHD/H4K12ac/K16ac complex was crystallized
in 20%PEGmonomethyl ether 2,000, 0.2M trimethylamine N-oxide, and 0.1M
Tris pH 8.5. Crystals were soaked in the corresponding mother liquor supple-
mented with 20% glycerol as cryoprotectant before freezing in liquid nitrogen.
Data Collection and Structure Determination
X-Ray diffraction data were collected at 100K at beamline X6A of the National
Synchrotron Light Source (NSLS) at Brookhaven National Laboratory. Data
were processed using the HKL-2000 suite (Otwinowski and Minor, 1997).
The structure of the CBP BrD-PHD was solved by molecular replacement us-
ing the programMOLREP (Vagin and Teplyakov, 2010). The crystal structure of
CBP BrD (Protein Data Bank ID code 3DWY) was used as the search model.
ARP/wARP (Perrakis et al., 2001) was used for automatic model building.
REFMAC (Murshudov et al., 1997) was used for structure refinement. Graphics
program COOT (Emsley and Cowtan, 2004) was used for model building and
visualization. Crystal diffraction data and refinement statistics for the structure
are displayed in Table 1.sticks, and carbon atoms are in light gray. The right panel shows structure supe
plexes. Surface representation of CBP is shown only. Residues involved in discri
atoms are colored in green.
See also Figure S4.
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